FDA NDC Directory · JSON-LD · Markdown

Crenessity

NDC 70370-5250 · HUMAN PRESCRIPTION DRUG · SOLUTION

Generic namecrinecerfont
Labeler / ManufacturerNeurocrine Biosciences, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA218820
Dosage form / routeSOLUTION · ORAL
Active ingredientsCRINECERFONT (50 mg/mL)
Marketing started20241213
Package count1

External sources

Source: openFDA. Public-domain (CC0).